

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drinking behavior (GO:0042756) | 7.09106590 |
| 2 | response to pheromone (GO:0019236) | 6.87289519 |
| 3 | left/right pattern formation (GO:0060972) | 6.61859602 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 5.62890729 |
| 5 | protein localization to endosome (GO:0036010) | 5.55879326 |
| 6 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 5.26989435 |
| 7 | negative regulation of interleukin-12 production (GO:0032695) | 5.16042045 |
| 8 | response to peptidoglycan (GO:0032494) | 5.06705578 |
| 9 | glycosphingolipid catabolic process (GO:0046479) | 4.92255009 |
| 10 | positive regulation of translational initiation (GO:0045948) | 4.90888020 |
| 11 | amino sugar catabolic process (GO:0046348) | 4.75988511 |
| 12 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.67866373 |
| 13 | glycolipid catabolic process (GO:0019377) | 4.42287294 |
| 14 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.41768347 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.41729990 |
| 16 | regulation of mast cell degranulation (GO:0043304) | 4.30056296 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 4.27281730 |
| 18 | regulation of dopamine secretion (GO:0014059) | 4.15360676 |
| 19 | dopamine transport (GO:0015872) | 4.12568159 |
| 20 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.08839841 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 4.02544098 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 4.02544098 |
| 23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.02544098 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.02544098 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.02544098 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 4.02544098 |
| 27 | regulation of mononuclear cell migration (GO:0071675) | 4.01605919 |
| 28 | GDP-mannose metabolic process (GO:0019673) | 3.93535713 |
| 29 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.93517976 |
| 30 | respiratory electron transport chain (GO:0022904) | 3.89439375 |
| 31 | ceramide catabolic process (GO:0046514) | 3.88904047 |
| 32 | electron transport chain (GO:0022900) | 3.87486485 |
| 33 | serotonin receptor signaling pathway (GO:0007210) | 3.85140017 |
| 34 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.84776824 |
| 35 | positive regulation of mast cell degranulation (GO:0043306) | 3.84776824 |
| 36 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.71511452 |
| 37 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.68413717 |
| 38 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.67687016 |
| 39 | regulation of leukocyte degranulation (GO:0043300) | 3.64833241 |
| 40 | N-acetylneuraminate metabolic process (GO:0006054) | 3.64545068 |
| 41 | oxidative phosphorylation (GO:0006119) | 3.63015862 |
| 42 | positive regulation of antigen processing and presentation (GO:0002579) | 3.62609061 |
| 43 | positive regulation of mast cell activation (GO:0033005) | 3.59443368 |
| 44 | ATP synthesis coupled proton transport (GO:0015986) | 3.56408549 |
| 45 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.56408549 |
| 46 | T-helper 1 type immune response (GO:0042088) | 3.56353515 |
| 47 | positive regulation of leukocyte degranulation (GO:0043302) | 3.55488165 |
| 48 | pentose metabolic process (GO:0019321) | 3.55344993 |
| 49 | granulocyte activation (GO:0036230) | 3.52762442 |
| 50 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.51033749 |
| 51 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.49433640 |
| 52 | protein targeting to peroxisome (GO:0006625) | 3.47298502 |
| 53 | establishment of protein localization to peroxisome (GO:0072663) | 3.47298502 |
| 54 | protein localization to peroxisome (GO:0072662) | 3.47298502 |
| 55 | peroxisomal transport (GO:0043574) | 3.45808705 |
| 56 | positive regulation of protein sumoylation (GO:0033235) | 3.44184209 |
| 57 | pinocytosis (GO:0006907) | 3.42805998 |
| 58 | response to thyroid hormone (GO:0097066) | 3.41974197 |
| 59 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.40353741 |
| 60 | membrane lipid catabolic process (GO:0046466) | 3.38631934 |
| 61 | myeloid dendritic cell differentiation (GO:0043011) | 3.38463073 |
| 62 | aerobic respiration (GO:0009060) | 3.37829066 |
| 63 | detection of molecule of bacterial origin (GO:0032490) | 3.37821348 |
| 64 | barbed-end actin filament capping (GO:0051016) | 3.37705754 |
| 65 | sphingolipid catabolic process (GO:0030149) | 3.35769673 |
| 66 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.35477675 |
| 67 | NADH dehydrogenase complex assembly (GO:0010257) | 3.35477675 |
| 68 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.35477675 |
| 69 | protein polyglutamylation (GO:0018095) | 3.33629679 |
| 70 | regulation of cholesterol storage (GO:0010885) | 3.29385787 |
| 71 | regulation of antigen processing and presentation (GO:0002577) | 3.28802625 |
| 72 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.27591464 |
| 73 | regulation of mast cell activation (GO:0033003) | 3.27130521 |
| 74 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.26739225 |
| 75 | GTP biosynthetic process (GO:0006183) | 3.25002892 |
| 76 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.24579983 |
| 77 | virion attachment to host cell (GO:0019062) | 3.24122963 |
| 78 | adhesion of symbiont to host cell (GO:0044650) | 3.24122963 |
| 79 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.23998405 |
| 80 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.23998405 |
| 81 | myeloid cell activation involved in immune response (GO:0002275) | 3.23473147 |
| 82 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.21928785 |
| 83 | 7-methylguanosine mRNA capping (GO:0006370) | 3.21475526 |
| 84 | glucosamine-containing compound catabolic process (GO:1901072) | 3.21026885 |
| 85 | mannose metabolic process (GO:0006013) | 3.18703437 |
| 86 | macrophage activation (GO:0042116) | 3.16763755 |
| 87 | G-protein coupled receptor internalization (GO:0002031) | 3.16611337 |
| 88 | myeloid dendritic cell activation (GO:0001773) | 3.16414961 |
| 89 | B cell mediated immunity (GO:0019724) | 3.16371054 |
| 90 | NIK/NF-kappaB signaling (GO:0038061) | 3.15931388 |
| 91 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.15844460 |
| 92 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.14470936 |
| 93 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.14162316 |
| 94 | pancreas development (GO:0031016) | 3.13272984 |
| 95 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.12278600 |
| 96 | negative regulation of cell killing (GO:0031342) | 3.12278600 |
| 97 | intracellular protein transmembrane transport (GO:0065002) | 3.08800797 |
| 98 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.08779380 |
| 99 | neutrophil activation (GO:0042119) | 3.07892397 |
| 100 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.06373138 |
| 101 | cellular response to epinephrine stimulus (GO:0071872) | 3.06215753 |
| 102 | RNA capping (GO:0036260) | 3.04293126 |
| 103 | 7-methylguanosine RNA capping (GO:0009452) | 3.04293126 |
| 104 | L-phenylalanine metabolic process (GO:0006558) | 3.02148704 |
| 105 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.02148704 |
| 106 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.01539319 |
| 107 | response to muramyl dipeptide (GO:0032495) | 3.00875419 |
| 108 | UTP biosynthetic process (GO:0006228) | 2.99953128 |
| 109 | regulation of podosome assembly (GO:0071801) | 2.99594305 |
| 110 | macrophage differentiation (GO:0030225) | 2.97918777 |
| 111 | adhesion of symbiont to host (GO:0044406) | 2.97840778 |
| 112 | adenosine receptor signaling pathway (GO:0001973) | 2.97071834 |
| 113 | monocyte chemotaxis (GO:0002548) | 2.96576458 |
| 114 | otic vesicle formation (GO:0030916) | 2.95829766 |
| 115 | protein complex biogenesis (GO:0070271) | 2.94622100 |
| 116 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.93169754 |
| 117 | detection of external biotic stimulus (GO:0098581) | 2.93013961 |
| 118 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.92769431 |
| 119 | regulation of macrophage chemotaxis (GO:0010758) | 2.92646298 |
| 120 | regulation of superoxide anion generation (GO:0032928) | 2.92589134 |
| 121 | regulation of oxidative stress-induced neuron death (GO:1903203) | 2.92248162 |
| 122 | detection of other organism (GO:0098543) | 2.91245905 |
| 123 | catecholamine transport (GO:0051937) | 2.90986669 |
| 124 | response to protozoan (GO:0001562) | 2.90278434 |
| 125 | protein transmembrane transport (GO:0071806) | 2.90031858 |
| 126 | regulation of chemokine biosynthetic process (GO:0045073) | 2.89349120 |
| 127 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.87434288 |
| 128 | positive regulation of heat generation (GO:0031652) | 2.86512975 |
| 129 | defense response to protozoan (GO:0042832) | 2.86501803 |
| 130 | dendritic cell differentiation (GO:0097028) | 2.85679432 |
| 131 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.85509872 |
| 132 | axoneme assembly (GO:0035082) | 2.85462230 |
| 133 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.84341722 |
| 134 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.83855412 |
| 135 | norepinephrine metabolic process (GO:0042415) | 2.83491263 |
| 136 | regulation of regulated secretory pathway (GO:1903305) | 2.82247468 |
| 137 | negative regulation of granulocyte differentiation (GO:0030853) | 2.81790420 |
| 138 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.81185229 |
| 139 | protein-cofactor linkage (GO:0018065) | 2.81151828 |
| 140 | germinal center formation (GO:0002467) | 2.80801017 |
| 141 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.80156825 |
| 142 | regulation of mitochondrial translation (GO:0070129) | 2.78061727 |
| 143 | positive regulation of cholesterol efflux (GO:0010875) | 2.77752473 |
| 144 | phagosome maturation (GO:0090382) | 2.77719387 |
| 145 | regulation of protein sumoylation (GO:0033233) | 2.76968735 |
| 146 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.76954889 |
| 147 | purine nucleobase biosynthetic process (GO:0009113) | 2.76153882 |
| 148 | respiratory burst (GO:0045730) | 2.74355837 |
| 149 | low-density lipoprotein particle clearance (GO:0034383) | 2.74283682 |
| 150 | eosinophil chemotaxis (GO:0048245) | 2.73255032 |
| 151 | histamine secretion (GO:0001821) | 2.72312820 |
| 152 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.72175505 |
| 153 | L-phenylalanine catabolic process (GO:0006559) | 2.72175505 |
| 154 | intracellular protein transmembrane import (GO:0044743) | 2.71162483 |
| 155 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.70464793 |
| 156 | UTP metabolic process (GO:0046051) | 2.70237986 |
| 157 | microglial cell activation (GO:0001774) | 2.68444526 |
| 158 | peroxisome organization (GO:0007031) | 2.67940540 |
| 159 | lytic vacuole organization (GO:0080171) | 2.67678124 |
| 160 | lysosome organization (GO:0007040) | 2.67678124 |
| 161 | detection of bacterium (GO:0016045) | 2.67656132 |
| 162 | regulation of monocyte chemotaxis (GO:0090025) | 2.66685594 |
| 163 | regulation of interferon-alpha production (GO:0032647) | 2.66576592 |
| 164 | centrosome localization (GO:0051642) | 2.64848541 |
| 165 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.64225949 |
| 166 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.63997923 |
| 167 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.58690071 |
| 168 | regulation of cholesterol metabolic process (GO:0090181) | 2.58266674 |
| 169 | transferrin transport (GO:0033572) | 2.58045608 |
| 170 | regulation of oxidative phosphorylation (GO:0002082) | 2.54824470 |
| 171 | hydrogen ion transmembrane transport (GO:1902600) | 2.53709441 |
| 172 | NADH metabolic process (GO:0006734) | 2.53546208 |
| 173 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.51707852 |
| 174 | folic acid metabolic process (GO:0046655) | 2.50880551 |
| 175 | trivalent inorganic cation transport (GO:0072512) | 2.49706079 |
| 176 | ferric iron transport (GO:0015682) | 2.49706079 |
| 177 | auditory receptor cell differentiation (GO:0042491) | 2.49162744 |
| 178 | cochlea development (GO:0090102) | 2.49124008 |
| 179 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.47841749 |
| 180 | cellular respiration (GO:0045333) | 2.46245178 |
| 181 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.46026537 |
| 182 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.45789427 |
| 183 | CTP metabolic process (GO:0046036) | 2.44238760 |
| 184 | CTP biosynthetic process (GO:0006241) | 2.44238760 |
| 185 | positive regulation of viral transcription (GO:0050434) | 2.43869039 |
| 186 | L-ascorbic acid metabolic process (GO:0019852) | 2.42351621 |
| 187 | sulfur amino acid catabolic process (GO:0000098) | 2.42045267 |
| 188 | response to nitrosative stress (GO:0051409) | 2.40442545 |
| 189 | platelet dense granule organization (GO:0060155) | 2.39044321 |
| 190 | branched-chain amino acid catabolic process (GO:0009083) | 2.38146906 |
| 191 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.37459987 |
| 192 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.37459987 |
| 193 | oligosaccharide catabolic process (GO:0009313) | 2.35672168 |
| 194 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.35303817 |
| 195 | cellular response to catecholamine stimulus (GO:0071870) | 2.33111122 |
| 196 | cellular response to monoamine stimulus (GO:0071868) | 2.33111122 |
| 197 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.32537978 |
| 198 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 2.32301841 |
| 199 | response to epinephrine (GO:0071871) | 2.32204961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.08857029 |
| 2 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 5.26047186 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.58336943 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.49584438 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.27073678 |
| 6 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 4.01559550 |
| 7 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.51027386 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.30204502 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.24564573 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.14417359 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.03321909 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85087841 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.81762563 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.80414760 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.75317395 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.70852009 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.51799788 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.39336255 |
| 19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.38818081 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.38417111 |
| 21 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.34476581 |
| 22 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.34237475 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29336196 |
| 24 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.26026817 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.25546176 |
| 26 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.25282610 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.24820584 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.24608062 |
| 29 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.21204035 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19642799 |
| 31 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.19171202 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 2.18551891 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.17971165 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.17726940 |
| 35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.14453210 |
| 36 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.12695753 |
| 37 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.11891682 |
| 38 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.09005327 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.08188969 |
| 40 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.02461293 |
| 41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.01284501 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.00567846 |
| 43 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.98018550 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.87577819 |
| 45 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.85104688 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.83402411 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.80595097 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80456377 |
| 49 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.79711060 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.79192287 |
| 51 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.78610706 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.77803381 |
| 53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.77696821 |
| 54 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.77239103 |
| 55 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.76782523 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76535762 |
| 57 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75799392 |
| 58 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.73230039 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73202641 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.70330307 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.69558588 |
| 62 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.68325115 |
| 63 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.66827298 |
| 64 | MAF_26560356_Chip-Seq_TH1_Human | 1.64498630 |
| 65 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.61704101 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61395117 |
| 67 | MYC_22102868_ChIP-Seq_BL_Human | 1.60380411 |
| 68 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.59404782 |
| 69 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.59323443 |
| 70 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59102111 |
| 71 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58439242 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.57939645 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54795395 |
| 74 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.53408694 |
| 75 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.52910703 |
| 76 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52513585 |
| 77 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.52431198 |
| 78 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.51560376 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.51470543 |
| 80 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.50830778 |
| 81 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.49355405 |
| 82 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47280280 |
| 83 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.47045937 |
| 84 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.45503055 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45217272 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.44860513 |
| 87 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.42454738 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.39606257 |
| 89 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.39451498 |
| 90 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.39103523 |
| 91 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.39103523 |
| 92 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.39103523 |
| 93 | UTX_26944678_Chip-Seq_JUKART_Human | 1.38999458 |
| 94 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.38983077 |
| 95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38527992 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38307979 |
| 97 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.38278152 |
| 98 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.37700258 |
| 99 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36178414 |
| 100 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.36170278 |
| 101 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36167857 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36024856 |
| 103 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.35398464 |
| 104 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34610642 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34469881 |
| 106 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34055421 |
| 107 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.34011653 |
| 108 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.33696723 |
| 109 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33618089 |
| 110 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.33468811 |
| 111 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.32831975 |
| 112 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.32236791 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31956093 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31878588 |
| 115 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29808773 |
| 116 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29235550 |
| 117 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.28567130 |
| 118 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.28418163 |
| 119 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27678893 |
| 120 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26744238 |
| 121 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26577663 |
| 122 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25633804 |
| 123 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23686630 |
| 124 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22083527 |
| 125 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21878530 |
| 126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21647924 |
| 127 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.20760818 |
| 128 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.19723862 |
| 129 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18947749 |
| 130 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.18782834 |
| 131 | MYB_26560356_Chip-Seq_TH2_Human | 1.17824851 |
| 132 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.17635382 |
| 133 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16803471 |
| 134 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.15855396 |
| 135 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.14175358 |
| 136 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13634010 |
| 137 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.12268649 |
| 138 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.12129331 |
| 139 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.11935909 |
| 140 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11913674 |
| 141 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09091337 |
| 142 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09038214 |
| 143 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08054513 |
| 144 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07994305 |
| 145 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06830822 |
| 146 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.06105091 |
| 147 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05752887 |
| 148 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05472567 |
| 149 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05321291 |
| 150 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.05055115 |
| 151 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05008933 |
| 152 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.04265096 |
| 153 | P68_20966046_ChIP-Seq_HELA_Human | 1.02663811 |
| 154 | VDR_22108803_ChIP-Seq_LS180_Human | 1.02646100 |
| 155 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02318216 |
| 156 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.01812606 |
| 157 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.01231133 |
| 158 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.00872927 |
| 159 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00661215 |
| 160 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.00633093 |
| 161 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.99418246 |
| 162 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99073094 |
| 163 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98750900 |
| 164 | MYB_26560356_Chip-Seq_TH1_Human | 0.98003369 |
| 165 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97709168 |
| 166 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.97552326 |
| 167 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.96990330 |
| 168 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.95794969 |
| 169 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95516192 |
| 170 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.95420540 |
| 171 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.95244979 |
| 172 | SA1_27219007_Chip-Seq_Bcells_Human | 0.94593637 |
| 173 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94421278 |
| 174 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.94352765 |
| 175 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.93967802 |
| 176 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93141131 |
| 177 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.92796654 |
| 178 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90847840 |
| 179 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.90845995 |
| 180 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.90474111 |
| 181 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.89853148 |
| 182 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.89714082 |
| 183 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.88500077 |
| 184 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.88302986 |
| 185 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.88004053 |
| 186 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87179394 |
| 187 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.85557973 |
| 188 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.84405223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.28989488 |
| 2 | MP0004133_heterotaxia | 4.66778591 |
| 3 | MP0003878_abnormal_ear_physiology | 4.18801519 |
| 4 | MP0005377_hearing/vestibular/ear_phenot | 4.18801519 |
| 5 | MP0003303_peritoneal_inflammation | 3.93714157 |
| 6 | MP0006082_CNS_inflammation | 3.67227548 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.64912027 |
| 8 | MP0009840_abnormal_foam_cell | 3.35765321 |
| 9 | MP0003436_decreased_susceptibility_to | 3.28944866 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 3.14865086 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 3.01221735 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.94598280 |
| 13 | MP0002419_abnormal_innate_immunity | 2.83537735 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.75062062 |
| 15 | MP0003724_increased_susceptibility_to | 2.70139924 |
| 16 | MP0003283_abnormal_digestive_organ | 2.62172077 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.59652847 |
| 18 | MP0005671_abnormal_response_to | 2.58696764 |
| 19 | MP0009785_altered_susceptibility_to | 2.58475806 |
| 20 | MP0008789_abnormal_olfactory_epithelium | 2.50814767 |
| 21 | MP0002132_abnormal_respiratory_system | 2.50018422 |
| 22 | MP0005025_abnormal_response_to | 2.45188733 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.37599801 |
| 24 | MP0001790_abnormal_immune_system | 2.36047004 |
| 25 | MP0005387_immune_system_phenotype | 2.36047004 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 2.29142364 |
| 27 | MP0004510_myositis | 2.27487941 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 2.26814459 |
| 29 | MP0000343_altered_response_to | 2.26538935 |
| 30 | MP0003075_altered_response_to | 2.21319159 |
| 31 | MP0003879_abnormal_hair_cell | 2.19398856 |
| 32 | MP0000604_amyloidosis | 2.14494450 |
| 33 | MP0002452_abnormal_antigen_presenting | 2.13307709 |
| 34 | MP0003300_gastrointestinal_ulcer | 2.10049143 |
| 35 | MP0009278_abnormal_bone_marrow | 2.07498513 |
| 36 | MP0003693_abnormal_embryo_hatching | 2.06804715 |
| 37 | MP0002723_abnormal_immune_serum | 2.06637579 |
| 38 | MP0001533_abnormal_skeleton_physiology | 2.04769334 |
| 39 | MP0005365_abnormal_bile_salt | 2.04765941 |
| 40 | MP0000685_abnormal_immune_system | 1.99657076 |
| 41 | MP0005451_abnormal_body_composition | 1.99018910 |
| 42 | MP0009764_decreased_sensitivity_to | 1.98279498 |
| 43 | MP0005085_abnormal_gallbladder_physiolo | 1.97968979 |
| 44 | MP0006292_abnormal_olfactory_placode | 1.95770562 |
| 45 | MP0005394_taste/olfaction_phenotype | 1.90743879 |
| 46 | MP0005499_abnormal_olfactory_system | 1.90743879 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.90142364 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.90142364 |
| 49 | MP0001800_abnormal_humoral_immune | 1.89082091 |
| 50 | MP0002735_abnormal_chemical_nociception | 1.86445277 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.80846598 |
| 52 | MP0001819_abnormal_immune_cell | 1.78575299 |
| 53 | MP0002420_abnormal_adaptive_immunity | 1.77717029 |
| 54 | MP0005670_abnormal_white_adipose | 1.75670503 |
| 55 | MP0001486_abnormal_startle_reflex | 1.74929784 |
| 56 | MP0001984_abnormal_olfaction | 1.73927607 |
| 57 | MP0000678_abnormal_parathyroid_gland | 1.73293146 |
| 58 | MP0001853_heart_inflammation | 1.71291370 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.70516247 |
| 60 | MP0003186_abnormal_redox_activity | 1.69971542 |
| 61 | MP0001485_abnormal_pinna_reflex | 1.69334558 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.68534509 |
| 63 | MP0003195_calcinosis | 1.67758783 |
| 64 | MP0008469_abnormal_protein_level | 1.64573428 |
| 65 | MP0005310_abnormal_salivary_gland | 1.64110514 |
| 66 | MP0002405_respiratory_system_inflammati | 1.63754085 |
| 67 | MP0009379_abnormal_foot_pigmentation | 1.62032274 |
| 68 | MP0002254_reproductive_system_inflammat | 1.59651175 |
| 69 | MP0000858_altered_metastatic_potential | 1.57030061 |
| 70 | MP0005464_abnormal_platelet_physiology | 1.54954039 |
| 71 | MP0003718_maternal_effect | 1.54143676 |
| 72 | MP0000751_myopathy | 1.53998857 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 1.51272126 |
| 74 | MP0008004_abnormal_stomach_pH | 1.49879767 |
| 75 | MP0006072_abnormal_retinal_apoptosis | 1.49362138 |
| 76 | MP0003690_abnormal_glial_cell | 1.49103826 |
| 77 | MP0004947_skin_inflammation | 1.48631506 |
| 78 | MP0010155_abnormal_intestine_physiology | 1.47460001 |
| 79 | MP0008260_abnormal_autophagy | 1.43128782 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.42136071 |
| 81 | MP0004043_abnormal_pH_regulation | 1.42015407 |
| 82 | MP0005360_urolithiasis | 1.39512871 |
| 83 | MP0003448_altered_tumor_morphology | 1.36811331 |
| 84 | MP0000026_abnormal_inner_ear | 1.36095752 |
| 85 | MP0006276_abnormal_autonomic_nervous | 1.35949356 |
| 86 | MP0001764_abnormal_homeostasis | 1.35484842 |
| 87 | MP0003011_delayed_dark_adaptation | 1.34901527 |
| 88 | MP0005220_abnormal_exocrine_pancreas | 1.33286921 |
| 89 | MP0001963_abnormal_hearing_physiology | 1.30736007 |
| 90 | MP0000534_abnormal_ureter_morphology | 1.30640089 |
| 91 | MP0001905_abnormal_dopamine_level | 1.30367338 |
| 92 | MP0003119_abnormal_digestive_system | 1.30063819 |
| 93 | MP0003828_pulmonary_edema | 1.28889674 |
| 94 | MP0002272_abnormal_nervous_system | 1.28556673 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 1.28168517 |
| 96 | MP0000716_abnormal_immune_system | 1.23589446 |
| 97 | MP0001529_abnormal_vocalization | 1.22910725 |
| 98 | MP0005166_decreased_susceptibility_to | 1.21537817 |
| 99 | MP0006054_spinal_hemorrhage | 1.20687302 |
| 100 | MP0003183_abnormal_peptide_metabolism | 1.17253633 |
| 101 | MP0002736_abnormal_nociception_after | 1.15698695 |
| 102 | MP0003123_paternal_imprinting | 1.14894733 |
| 103 | MP0002277_abnormal_respiratory_mucosa | 1.14299820 |
| 104 | MP0003656_abnormal_erythrocyte_physiolo | 1.12779954 |
| 105 | MP0008872_abnormal_physiological_respon | 1.11558994 |
| 106 | MP0003938_abnormal_ear_development | 1.10682477 |
| 107 | MP0002876_abnormal_thyroid_physiology | 1.10285031 |
| 108 | MP0006035_abnormal_mitochondrial_morpho | 1.06422456 |
| 109 | MP0003122_maternal_imprinting | 1.04500148 |
| 110 | MP0010329_abnormal_lipoprotein_level | 1.03420966 |
| 111 | MP0008932_abnormal_embryonic_tissue | 1.02102495 |
| 112 | MP0000689_abnormal_spleen_morphology | 1.01837723 |
| 113 | MP0002398_abnormal_bone_marrow | 1.00966973 |
| 114 | MP0004134_abnormal_chest_morphology | 0.98635799 |
| 115 | MP0002429_abnormal_blood_cell | 0.97411378 |
| 116 | MP0002184_abnormal_innervation | 0.96680085 |
| 117 | MP0001440_abnormal_grooming_behavior | 0.96145614 |
| 118 | MP0005636_abnormal_mineral_homeostasis | 0.95406122 |
| 119 | MP0003121_genomic_imprinting | 0.94070353 |
| 120 | MP0003942_abnormal_urinary_system | 0.93756468 |
| 121 | MP0010307_abnormal_tumor_latency | 0.93729764 |
| 122 | MP0000013_abnormal_adipose_tissue | 0.93154762 |
| 123 | MP0005330_cardiomyopathy | 0.92713719 |
| 124 | MP0005645_abnormal_hypothalamus_physiol | 0.92452756 |
| 125 | MP0004885_abnormal_endolymph | 0.91452610 |
| 126 | MP0005248_abnormal_Harderian_gland | 0.91007217 |
| 127 | MP0003787_abnormal_imprinting | 0.90826045 |
| 128 | MP0009745_abnormal_behavioral_response | 0.90631642 |
| 129 | MP0000920_abnormal_myelination | 0.90510845 |
| 130 | MP0005535_abnormal_body_temperature | 0.90453974 |
| 131 | MP0003329_amyloid_beta_deposits | 0.90433838 |
| 132 | MP0008058_abnormal_DNA_repair | 0.90281399 |
| 133 | MP0005165_increased_susceptibility_to | 0.90204588 |
| 134 | MP0002111_abnormal_tail_morphology | 0.89818452 |
| 135 | MP0001666_abnormal_nutrient_absorption | 0.88981728 |
| 136 | MP0000465_gastrointestinal_hemorrhage | 0.88491563 |
| 137 | MP0002722_abnormal_immune_system | 0.88255131 |
| 138 | MP0001851_eye_inflammation | 0.88198358 |
| 139 | MP0005390_skeleton_phenotype | 0.87561081 |
| 140 | MP0002557_abnormal_social/conspecific_i | 0.85853691 |
| 141 | MP0003279_aneurysm | 0.85725136 |
| 142 | MP0009763_increased_sensitivity_to | 0.84615346 |
| 143 | MP0005266_abnormal_metabolism | 0.84348997 |
| 144 | MP0000358_abnormal_cell_content/ | 0.84025403 |
| 145 | MP0000537_abnormal_urethra_morphology | 0.83969570 |
| 146 | MP0001919_abnormal_reproductive_system | 0.82201061 |
| 147 | MP0001542_abnormal_bone_strength | 0.80693947 |
| 148 | MP0001663_abnormal_digestive_system | 0.79503924 |
| 149 | MP0000778_abnormal_nervous_system | 0.79312565 |
| 150 | MP0002877_abnormal_melanocyte_morpholog | 0.78052208 |
| 151 | MP0008877_abnormal_DNA_methylation | 0.77240548 |
| 152 | MP0008057_abnormal_DNA_replication | 0.76280091 |
| 153 | MP0005409_darkened_coat_color | 0.75850394 |
| 154 | MP0005319_abnormal_enzyme/_coenzyme | 0.75701850 |
| 155 | MP0003795_abnormal_bone_structure | 0.75260964 |
| 156 | MP0009250_abnormal_appendicular_skeleto | 0.75036983 |
| 157 | MP0005389_reproductive_system_phenotype | 0.74549469 |
| 158 | MP0005332_abnormal_amino_acid | 0.74245309 |
| 159 | MP0002752_abnormal_somatic_nervous | 0.72924181 |
| 160 | MP0005164_abnormal_response_to | 0.72588369 |
| 161 | MP0002063_abnormal_learning/memory/cond | 0.71358151 |
| 162 | MP0002118_abnormal_lipid_homeostasis | 0.71224410 |
| 163 | MP0001944_abnormal_pancreas_morphology | 0.70544725 |
| 164 | MP0000490_abnormal_crypts_of | 0.70271057 |
| 165 | MP0004957_abnormal_blastocyst_morpholog | 0.69881939 |
| 166 | MP0001873_stomach_inflammation | 0.68980103 |
| 167 | MP0002734_abnormal_mechanical_nocicepti | 0.68897574 |
| 168 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68695366 |
| 169 | MP0005647_abnormal_sex_gland | 0.68145795 |
| 170 | MP0002269_muscular_atrophy | 0.67126213 |
| 171 | MP0001177_atelectasis | 0.66450381 |
| 172 | MP0000609_abnormal_liver_physiology | 0.66362152 |
| 173 | MP0005408_hypopigmentation | 0.65824203 |
| 174 | MP0001968_abnormal_touch/_nociception | 0.65453764 |
| 175 | MP0000049_abnormal_middle_ear | 0.65177531 |
| 176 | MP0004883_abnormal_blood_vessel | 0.65048395 |
| 177 | MP0009765_abnormal_xenobiotic_induced | 0.64876541 |
| 178 | MP0001970_abnormal_pain_threshold | 0.64458875 |
| 179 | MP0003634_abnormal_glial_cell | 0.64263693 |
| 180 | MP0004019_abnormal_vitamin_homeostasis | 0.63630762 |
| 181 | MP0001849_ear_inflammation | 0.63358516 |
| 182 | MP0002653_abnormal_ependyma_morphology | 0.63296094 |
| 183 | MP0009053_abnormal_anal_canal | 0.63180701 |
| 184 | MP0000249_abnormal_blood_vessel | 0.62968141 |
| 185 | MP0002928_abnormal_bile_duct | 0.62582705 |
| 186 | MP0002229_neurodegeneration | 0.61847972 |
| 187 | MP0002933_joint_inflammation | 0.60793237 |
| 188 | MP0004185_abnormal_adipocyte_glucose | 0.56975510 |
| 189 | MP0002138_abnormal_hepatobiliary_system | 0.56159983 |
| 190 | MP0005076_abnormal_cell_differentiation | 0.52342959 |
| 191 | MP0002090_abnormal_vision | 0.52319388 |
| 192 | MP0002332_abnormal_exercise_endurance | 0.50815524 |
| 193 | MP0008874_decreased_physiological_sensi | 0.49513667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.99628108 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.99628108 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.99628108 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.85980513 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 5.67938032 |
| 6 | Renal cortical cysts (HP:0000803) | 5.62512341 |
| 7 | Tubulointerstitial nephritis (HP:0001970) | 5.38012983 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 5.26038221 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.09342076 |
| 10 | Dysostosis multiplex (HP:0000943) | 5.08017407 |
| 11 | Disinhibition (HP:0000734) | 5.02734593 |
| 12 | Stenosis of the external auditory canal (HP:0000402) | 4.98970288 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.75095059 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 4.54485269 |
| 15 | Recurrent abscess formation (HP:0002722) | 4.51138717 |
| 16 | Loss of speech (HP:0002371) | 4.40021466 |
| 17 | Abnormal hemoglobin (HP:0011902) | 4.22583601 |
| 18 | Mutism (HP:0002300) | 4.15955957 |
| 19 | Acute necrotizing encephalopathy (HP:0006965) | 4.04880944 |
| 20 | Aplasia involving bones of the extremities (HP:0009825) | 3.94335547 |
| 21 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.94335547 |
| 22 | Aplasia of the phalanges of the hand (HP:0009802) | 3.94335547 |
| 23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.91649388 |
| 24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.91649388 |
| 25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.91649388 |
| 26 | Brushfield spots (HP:0001088) | 3.90010254 |
| 27 | Eczematoid dermatitis (HP:0000976) | 3.88589539 |
| 28 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.75420586 |
| 29 | Axonal loss (HP:0003447) | 3.73474955 |
| 30 | Mucopolysacchariduria (HP:0008155) | 3.64216567 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.64216567 |
| 32 | Lip pit (HP:0100267) | 3.62926013 |
| 33 | Fibular aplasia (HP:0002990) | 3.61172223 |
| 34 | Hyperkalemia (HP:0002153) | 3.61063734 |
| 35 | Acute encephalopathy (HP:0006846) | 3.60808532 |
| 36 | Hepatocellular necrosis (HP:0001404) | 3.57612981 |
| 37 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.47599589 |
| 38 | Enlarged kidneys (HP:0000105) | 3.46983973 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.43293802 |
| 40 | Glomerulonephritis (HP:0000099) | 3.43219962 |
| 41 | Hepatic necrosis (HP:0002605) | 3.40496764 |
| 42 | Nuclear cataract (HP:0100018) | 3.35441293 |
| 43 | Spontaneous hematomas (HP:0007420) | 3.30842308 |
| 44 | Mitochondrial inheritance (HP:0001427) | 3.29563768 |
| 45 | Delayed CNS myelination (HP:0002188) | 3.25411147 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 3.21164624 |
| 47 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.20871427 |
| 48 | Short 1st metacarpal (HP:0010034) | 3.20871427 |
| 49 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.17012692 |
| 50 | Progressive macrocephaly (HP:0004481) | 3.12623857 |
| 51 | Orchitis (HP:0100796) | 3.09931631 |
| 52 | Myositis (HP:0100614) | 3.07740282 |
| 53 | Agnosia (HP:0010524) | 3.06671101 |
| 54 | Upper motor neuron abnormality (HP:0002127) | 3.06171050 |
| 55 | Purpura (HP:0000979) | 2.99750939 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.98043415 |
| 57 | Increased CSF lactate (HP:0002490) | 2.93664187 |
| 58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.87502485 |
| 59 | Respiratory failure (HP:0002878) | 2.87137625 |
| 60 | Chronic obstructive pulmonary disease (HP:0006510) | 2.83635542 |
| 61 | Obstructive lung disease (HP:0006536) | 2.83635542 |
| 62 | Cerebral edema (HP:0002181) | 2.83557638 |
| 63 | Neurofibrillary tangles (HP:0002185) | 2.82845557 |
| 64 | Fibular hypoplasia (HP:0003038) | 2.81701453 |
| 65 | Apathy (HP:0000741) | 2.80083165 |
| 66 | Abnormality of the renal cortex (HP:0011035) | 2.76903696 |
| 67 | Diminished motivation (HP:0000745) | 2.76779840 |
| 68 | Amyloidosis (HP:0011034) | 2.75189455 |
| 69 | Retrobulbar optic neuritis (HP:0100654) | 2.74279591 |
| 70 | Optic neuritis (HP:0100653) | 2.74279591 |
| 71 | Inappropriate behavior (HP:0000719) | 2.72664611 |
| 72 | Complement deficiency (HP:0004431) | 2.71551591 |
| 73 | Increased serum ferritin (HP:0003281) | 2.70223228 |
| 74 | Abnormality of the 1st metacarpal (HP:0010009) | 2.69833424 |
| 75 | Glossoptosis (HP:0000162) | 2.69402038 |
| 76 | Recurrent skin infections (HP:0001581) | 2.66422642 |
| 77 | Stomatitis (HP:0010280) | 2.65605127 |
| 78 | Thoracic kyphosis (HP:0002942) | 2.62316210 |
| 79 | Facial hemangioma (HP:0000329) | 2.61574581 |
| 80 | Osteomalacia (HP:0002749) | 2.60503939 |
| 81 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.56060768 |
| 82 | Progressive neurologic deterioration (HP:0002344) | 2.54990013 |
| 83 | Neuronal loss in central nervous system (HP:0002529) | 2.54558471 |
| 84 | Petechiae (HP:0000967) | 2.51969241 |
| 85 | Pathologic fracture (HP:0002756) | 2.50668122 |
| 86 | Hepatosplenomegaly (HP:0001433) | 2.47019872 |
| 87 | Abnormality of the diencephalon (HP:0010662) | 2.45246002 |
| 88 | Hematochezia (HP:0002573) | 2.45134779 |
| 89 | Personality changes (HP:0000751) | 2.45099474 |
| 90 | Abnormality of the renal medulla (HP:0100957) | 2.42574920 |
| 91 | Abnormality of glycolysis (HP:0004366) | 2.40823607 |
| 92 | Increased serum pyruvate (HP:0003542) | 2.40823607 |
| 93 | Pancreatic cysts (HP:0001737) | 2.40509411 |
| 94 | Molar tooth sign on MRI (HP:0002419) | 2.39994920 |
| 95 | Abnormality of midbrain morphology (HP:0002418) | 2.39994920 |
| 96 | Myocardial infarction (HP:0001658) | 2.39859875 |
| 97 | Broad alveolar ridges (HP:0000187) | 2.30433941 |
| 98 | Gingivitis (HP:0000230) | 2.29657659 |
| 99 | Bell-shaped thorax (HP:0001591) | 2.29391030 |
| 100 | Hypoplasia of the uterus (HP:0000013) | 2.27046659 |
| 101 | Thickened nuchal skin fold (HP:0000474) | 2.26474735 |
| 102 | Vertebral compression fractures (HP:0002953) | 2.24079725 |
| 103 | Abnormality of complement system (HP:0005339) | 2.23083825 |
| 104 | Hyperglycinuria (HP:0003108) | 2.23069255 |
| 105 | Recurrent fungal infections (HP:0002841) | 2.22388760 |
| 106 | Dementia (HP:0000726) | 2.22159720 |
| 107 | Popliteal pterygium (HP:0009756) | 2.22012372 |
| 108 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.20520050 |
| 109 | Mixed hearing impairment (HP:0000410) | 2.20069825 |
| 110 | Posterior embryotoxon (HP:0000627) | 2.19014814 |
| 111 | Gout (HP:0001997) | 2.17280526 |
| 112 | Posterior subcapsular cataract (HP:0007787) | 2.16286308 |
| 113 | Nasolacrimal duct obstruction (HP:0000579) | 2.14661634 |
| 114 | Shawl scrotum (HP:0000049) | 2.14623235 |
| 115 | Meningitis (HP:0001287) | 2.13577380 |
| 116 | Polyneuropathy (HP:0001271) | 2.13449269 |
| 117 | Retinal atrophy (HP:0001105) | 2.11876588 |
| 118 | Abnormality of the labia minora (HP:0012880) | 2.09598136 |
| 119 | Hypochromic microcytic anemia (HP:0004840) | 2.09370918 |
| 120 | Lethargy (HP:0001254) | 2.08355226 |
| 121 | Abnormality of iron homeostasis (HP:0011031) | 2.07841885 |
| 122 | Pulmonary infiltrates (HP:0002113) | 2.05584463 |
| 123 | Abnormality of the line of Schwalbe (HP:0008048) | 2.05305362 |
| 124 | J-shaped sella turcica (HP:0002680) | 2.03945513 |
| 125 | Basal ganglia calcification (HP:0002135) | 2.02904536 |
| 126 | Urticaria (HP:0001025) | 2.02902412 |
| 127 | Metaphyseal irregularity (HP:0003025) | 2.02298659 |
| 128 | X-linked dominant inheritance (HP:0001423) | 2.01662005 |
| 129 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.01177196 |
| 130 | Conjunctival telangiectasia (HP:0000524) | 2.00945822 |
| 131 | Prolonged neonatal jaundice (HP:0006579) | 1.98405713 |
| 132 | Epiphyseal stippling (HP:0010655) | 1.97190423 |
| 133 | Pustule (HP:0200039) | 1.97132216 |
| 134 | Hemoptysis (HP:0002105) | 1.96813358 |
| 135 | Beaking of vertebral bodies (HP:0004568) | 1.96041620 |
| 136 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.95054484 |
| 137 | Ketoacidosis (HP:0001993) | 1.94464661 |
| 138 | CNS demyelination (HP:0007305) | 1.93696586 |
| 139 | Cerebral inclusion bodies (HP:0100314) | 1.93681598 |
| 140 | Peripheral demyelination (HP:0011096) | 1.93188396 |
| 141 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.93058099 |
| 142 | Recurrent cutaneous fungal infections (HP:0011370) | 1.93058099 |
| 143 | Metabolic acidosis (HP:0001942) | 1.92904558 |
| 144 | Exercise intolerance (HP:0003546) | 1.91967612 |
| 145 | Multicystic kidney dysplasia (HP:0000003) | 1.90202991 |
| 146 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.89701991 |
| 147 | Long clavicles (HP:0000890) | 1.87483968 |
| 148 | Glucose intolerance (HP:0000833) | 1.86397777 |
| 149 | Cardiomegaly (HP:0001640) | 1.86387334 |
| 150 | Oligohydramnios (HP:0001562) | 1.86015060 |
| 151 | Abnormality of the lumbar spine (HP:0100712) | 1.85957973 |
| 152 | Abnormality of the thoracic spine (HP:0100711) | 1.85567226 |
| 153 | Malnutrition (HP:0004395) | 1.85394943 |
| 154 | Thoracolumbar scoliosis (HP:0002944) | 1.84377694 |
| 155 | Bone pain (HP:0002653) | 1.83536698 |
| 156 | Cellulitis (HP:0100658) | 1.83405343 |
| 157 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.82902863 |
| 158 | Asymmetric septal hypertrophy (HP:0001670) | 1.82765029 |
| 159 | Supranuclear gaze palsy (HP:0000605) | 1.82555137 |
| 160 | Vasculitis (HP:0002633) | 1.82281153 |
| 161 | Severe global developmental delay (HP:0011344) | 1.81272702 |
| 162 | Tubulointerstitial abnormality (HP:0001969) | 1.80720536 |
| 163 | Progressive visual loss (HP:0000529) | 1.79229195 |
| 164 | Recurrent viral infections (HP:0004429) | 1.77973898 |
| 165 | Microtia (HP:0008551) | 1.76557062 |
| 166 | Increased serum lactate (HP:0002151) | 1.76378388 |
| 167 | Keratoconjunctivitis sicca (HP:0001097) | 1.76117929 |
| 168 | Epileptiform EEG discharges (HP:0011182) | 1.75767335 |
| 169 | Overfolded helix (HP:0000396) | 1.75289457 |
| 170 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.74703454 |
| 171 | Abnormality of glycine metabolism (HP:0010895) | 1.74703454 |
| 172 | Synostosis involving the elbow (HP:0003938) | 1.73842735 |
| 173 | Humeroradial synostosis (HP:0003041) | 1.73842735 |
| 174 | Memory impairment (HP:0002354) | 1.73077433 |
| 175 | Hypsarrhythmia (HP:0002521) | 1.73072885 |
| 176 | Gastrointestinal infarctions (HP:0005244) | 1.72879972 |
| 177 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.71613683 |
| 178 | Abnormality of the nasal mucosa (HP:0000433) | 1.70844549 |
| 179 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.70519810 |
| 180 | Hypoplastic scapulae (HP:0000882) | 1.70519810 |
| 181 | Hypoplasia of the fovea (HP:0007750) | 1.70056640 |
| 182 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.70056640 |
| 183 | Lactic acidosis (HP:0003128) | 1.70056556 |
| 184 | EEG with generalized epileptiform discharges (HP:0011198) | 1.70004073 |
| 185 | Hypoplastic nipples (HP:0002557) | 1.69795508 |
| 186 | Leukodystrophy (HP:0002415) | 1.69602900 |
| 187 | Arterial thrombosis (HP:0004420) | 1.69524227 |
| 188 | Nephritis (HP:0000123) | 1.69086403 |
| 189 | Encephalitis (HP:0002383) | 1.68923406 |
| 190 | Opisthotonus (HP:0002179) | 1.67506503 |
| 191 | Increased circulating renin level (HP:0000848) | 1.67353907 |
| 192 | Epistaxis (HP:0000421) | 1.67239238 |
| 193 | Turricephaly (HP:0000262) | 1.66171791 |
| 194 | Pancreatic fibrosis (HP:0100732) | 1.64044270 |
| 195 | Cystic liver disease (HP:0006706) | 1.62778965 |
| 196 | Abnormality of the lacrimal duct (HP:0011481) | 1.61699379 |
| 197 | Optic disc pallor (HP:0000543) | 1.61599141 |
| 198 | Neoplasm of the oral cavity (HP:0100649) | 1.61375534 |
| 199 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.59999491 |
| 200 | Microretrognathia (HP:0000308) | 1.59673715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 5.97181113 |
| 2 | PNCK | 4.17424304 |
| 3 | TESK2 | 3.54066999 |
| 4 | IRAK3 | 3.46994498 |
| 5 | BLK | 3.25573493 |
| 6 | MAPKAPK3 | 3.20541123 |
| 7 | BUB1 | 3.02136170 |
| 8 | MAP3K14 | 2.93538672 |
| 9 | EEF2K | 2.83077322 |
| 10 | EPHA2 | 2.75761170 |
| 11 | IRAK4 | 2.71983978 |
| 12 | TGFBR2 | 2.69836084 |
| 13 | ERN1 | 2.66642144 |
| 14 | MAP3K11 | 2.65576624 |
| 15 | MAP3K13 | 2.62276941 |
| 16 | ZAK | 2.53987678 |
| 17 | BCKDK | 2.52373621 |
| 18 | RIPK4 | 2.45822449 |
| 19 | TYK2 | 2.26994909 |
| 20 | TBK1 | 2.21218932 |
| 21 | TAOK2 | 2.11779665 |
| 22 | RPS6KB2 | 2.03421079 |
| 23 | GRK7 | 2.02087884 |
| 24 | MATK | 2.00100943 |
| 25 | TAOK1 | 1.89905381 |
| 26 | CSK | 1.88793696 |
| 27 | NTRK3 | 1.84864644 |
| 28 | PRPF4B | 1.84632791 |
| 29 | PAK3 | 1.82940678 |
| 30 | STK16 | 1.81319955 |
| 31 | MAP4K1 | 1.81033629 |
| 32 | LATS2 | 1.79962409 |
| 33 | STK38L | 1.78146227 |
| 34 | MAPK15 | 1.76872770 |
| 35 | FGR | 1.73384436 |
| 36 | MAP2K3 | 1.71372742 |
| 37 | MAPK13 | 1.70163533 |
| 38 | FES | 1.69823153 |
| 39 | IKBKB | 1.64889883 |
| 40 | PLK3 | 1.62157514 |
| 41 | ARAF | 1.58515813 |
| 42 | ACVR1B | 1.55867129 |
| 43 | CSF1R | 1.48050657 |
| 44 | CSNK1G2 | 1.46709948 |
| 45 | EIF2AK3 | 1.46333960 |
| 46 | DDR2 | 1.45832043 |
| 47 | VRK1 | 1.45110467 |
| 48 | JAK3 | 1.44814316 |
| 49 | MAPKAPK5 | 1.44062442 |
| 50 | LMTK2 | 1.41445175 |
| 51 | CAMK1D | 1.38846119 |
| 52 | CAMKK2 | 1.37347324 |
| 53 | NEK1 | 1.36716151 |
| 54 | MAP2K4 | 1.36507556 |
| 55 | ABL2 | 1.32227508 |
| 56 | PHKG2 | 1.30636522 |
| 57 | PHKG1 | 1.30636522 |
| 58 | RIPK1 | 1.27419576 |
| 59 | MAP2K2 | 1.25473250 |
| 60 | TNIK | 1.20341237 |
| 61 | TTK | 1.18851976 |
| 62 | MAP3K2 | 1.15560166 |
| 63 | MAP3K3 | 1.15268092 |
| 64 | ZAP70 | 1.12369153 |
| 65 | PDK4 | 1.12169305 |
| 66 | PDK3 | 1.12169305 |
| 67 | DYRK2 | 1.11571286 |
| 68 | PTK2 | 1.11257460 |
| 69 | IKBKE | 1.11065328 |
| 70 | MAP2K6 | 1.09145008 |
| 71 | MARK1 | 1.08403987 |
| 72 | BRAF | 1.07125952 |
| 73 | UHMK1 | 1.06334466 |
| 74 | LYN | 1.06155505 |
| 75 | SYK | 1.04125404 |
| 76 | TESK1 | 1.03997156 |
| 77 | MOS | 1.02640416 |
| 78 | TXK | 1.00972901 |
| 79 | MAP3K1 | 0.99608304 |
| 80 | SIK3 | 0.98589635 |
| 81 | MINK1 | 0.87908894 |
| 82 | MAP2K1 | 0.87801763 |
| 83 | TNK2 | 0.87679684 |
| 84 | EPHA4 | 0.86702052 |
| 85 | GRK6 | 0.86648595 |
| 86 | ADRBK2 | 0.85852966 |
| 87 | HCK | 0.85580400 |
| 88 | AURKA | 0.84828804 |
| 89 | CDC42BPA | 0.83431163 |
| 90 | SMG1 | 0.81504127 |
| 91 | CSNK1E | 0.81406168 |
| 92 | MARK3 | 0.81145484 |
| 93 | KIT | 0.78195614 |
| 94 | NME1 | 0.76720774 |
| 95 | SIK1 | 0.75406632 |
| 96 | BTK | 0.75400253 |
| 97 | PRKCG | 0.74698793 |
| 98 | NLK | 0.73130442 |
| 99 | PDPK1 | 0.70249315 |
| 100 | LCK | 0.69801226 |
| 101 | PLK1 | 0.69161762 |
| 102 | ICK | 0.68089742 |
| 103 | BCR | 0.67732971 |
| 104 | PRKCI | 0.67132878 |
| 105 | LATS1 | 0.66654692 |
| 106 | MST4 | 0.65932307 |
| 107 | GRK5 | 0.65112222 |
| 108 | TGFBR1 | 0.64339902 |
| 109 | CHUK | 0.63503026 |
| 110 | MAP2K7 | 0.61376714 |
| 111 | PAK4 | 0.60607514 |
| 112 | TSSK6 | 0.60438504 |
| 113 | RPS6KC1 | 0.59909538 |
| 114 | RPS6KL1 | 0.59909538 |
| 115 | INSRR | 0.59510211 |
| 116 | CSNK2A2 | 0.58238273 |
| 117 | MAP3K5 | 0.58080659 |
| 118 | JAK2 | 0.57251645 |
| 119 | PIM2 | 0.57015313 |
| 120 | ADRBK1 | 0.56825714 |
| 121 | WNK3 | 0.54949335 |
| 122 | PASK | 0.52533303 |
| 123 | MAP3K6 | 0.52412224 |
| 124 | TRIB3 | 0.52403143 |
| 125 | PDK2 | 0.51594836 |
| 126 | STK39 | 0.49402661 |
| 127 | TRPM7 | 0.48909168 |
| 128 | CSNK1G3 | 0.48250654 |
| 129 | IRAK2 | 0.48112415 |
| 130 | DAPK1 | 0.47862963 |
| 131 | RPS6KA6 | 0.47487411 |
| 132 | CAMK1G | 0.46534280 |
| 133 | EIF2AK2 | 0.46499147 |
| 134 | ERBB3 | 0.46488382 |
| 135 | PRKACA | 0.46061371 |
| 136 | PRKD2 | 0.45718007 |
| 137 | BMPR2 | 0.45451071 |
| 138 | CDK4 | 0.45162118 |
| 139 | NME2 | 0.45042310 |
| 140 | STK10 | 0.44945047 |
| 141 | MAP3K4 | 0.44698761 |
| 142 | MAPK4 | 0.44651616 |
| 143 | STK4 | 0.44395108 |
| 144 | PLK2 | 0.43834233 |
| 145 | TEC | 0.43135281 |
| 146 | WEE1 | 0.43047703 |
| 147 | PRKCE | 0.43044294 |
| 148 | RPS6KA2 | 0.43002096 |
| 149 | RPS6KB1 | 0.42753432 |
| 150 | CDK6 | 0.42161615 |
| 151 | KDR | 0.40823895 |
| 152 | TLK1 | 0.40582674 |
| 153 | MAP3K8 | 0.40173569 |
| 154 | PDK1 | 0.40119096 |
| 155 | TAOK3 | 0.40079655 |
| 156 | CAMK2G | 0.39868842 |
| 157 | CSNK2A1 | 0.39834001 |
| 158 | CAMK2B | 0.39770189 |
| 159 | SIK2 | 0.39674259 |
| 160 | CAMKK1 | 0.39275409 |
| 161 | ILK | 0.38850414 |
| 162 | NEK2 | 0.38460924 |
| 163 | TIE1 | 0.37690075 |
| 164 | ERBB2 | 0.36135628 |
| 165 | MAPK12 | 0.35728559 |
| 166 | JAK1 | 0.35210242 |
| 167 | MARK2 | 0.35068404 |
| 168 | MYLK | 0.34541713 |
| 169 | IRAK1 | 0.33363818 |
| 170 | PBK | 0.32513796 |
| 171 | CSNK1A1L | 0.31689196 |
| 172 | PRKCD | 0.31110804 |
| 173 | ITK | 0.30842871 |
| 174 | NEK9 | 0.30713946 |
| 175 | PIM1 | 0.30638932 |
| 176 | MAPK7 | 0.29556914 |
| 177 | CAMK2D | 0.29493364 |
| 178 | YES1 | 0.29425334 |
| 179 | DYRK1B | 0.29415648 |
| 180 | MELK | 0.28525194 |
| 181 | ABL1 | 0.28251641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.94470112 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.83397403 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.61840644 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.36217942 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.26418219 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.22405517 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.94526874 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.87035688 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.78668618 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.73835746 |
| 11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.54666599 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.35755481 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.34653174 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 2.34210941 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 2.29612688 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.26294229 |
| 17 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.22418456 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.10194785 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.05058980 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02154966 |
| 21 | Huntingtons disease_Homo sapiens_hsa05016 | 2.01858291 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.00693385 |
| 23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.00496142 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 2.00260383 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.94530440 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.92278111 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.90733137 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.85298400 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.85158038 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.83620783 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.82459165 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79848325 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.79771587 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.79589849 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.78009989 |
| 36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.77288229 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.77180671 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.71918582 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.71547967 |
| 40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.70315028 |
| 41 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.64599823 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59598082 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.59549211 |
| 44 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.59051510 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.56909458 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.56795372 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.54358972 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 1.54301077 |
| 49 | Ribosome_Homo sapiens_hsa03010 | 1.52492211 |
| 50 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.51428033 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50384492 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.50169045 |
| 53 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.49557816 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.48273426 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.46659361 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45642347 |
| 57 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.44110744 |
| 58 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.42376767 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.40321349 |
| 60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39764261 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.38899909 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.35734696 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.35480561 |
| 64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33487522 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.31515508 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30452667 |
| 67 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29882600 |
| 68 | Influenza A_Homo sapiens_hsa05164 | 1.28530567 |
| 69 | Proteasome_Homo sapiens_hsa03050 | 1.27848062 |
| 70 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24947061 |
| 71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.23606927 |
| 72 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.23208271 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22814483 |
| 74 | Taste transduction_Homo sapiens_hsa04742 | 1.21248289 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18362772 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17053786 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 1.16243986 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.10967255 |
| 79 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10747361 |
| 80 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10309778 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09476863 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.08548780 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.06476855 |
| 84 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.04827156 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03576296 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.02202367 |
| 87 | Purine metabolism_Homo sapiens_hsa00230 | 1.01941726 |
| 88 | Mismatch repair_Homo sapiens_hsa03430 | 1.00548240 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.97379264 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.96518708 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.96319445 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95944678 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.95871369 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.94222687 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94082587 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93566805 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92323609 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.90389655 |
| 99 | Spliceosome_Homo sapiens_hsa03040 | 0.88034312 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.86893024 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | 0.86718234 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84591436 |
| 103 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84365682 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84267353 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84231553 |
| 106 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.83939993 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.81884436 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81269169 |
| 109 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.79787433 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.78957891 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.78813707 |
| 112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78551209 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.78452017 |
| 114 | Measles_Homo sapiens_hsa05162 | 0.75565324 |
| 115 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74521443 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74271879 |
| 117 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.73686427 |
| 118 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73408799 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72890362 |
| 120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72703125 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | 0.71726850 |
| 122 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70946640 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69838829 |
| 124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67245048 |
| 125 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.67082143 |
| 126 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67055393 |
| 127 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65134472 |
| 128 | Hepatitis B_Homo sapiens_hsa05161 | 0.64830975 |
| 129 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64451386 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63986381 |
| 131 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.63374402 |
| 132 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62919130 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57122319 |
| 134 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57091289 |
| 135 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.56586398 |
| 136 | DNA replication_Homo sapiens_hsa03030 | 0.56517803 |
| 137 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56007059 |
| 138 | RNA transport_Homo sapiens_hsa03013 | 0.54402178 |
| 139 | Endocytosis_Homo sapiens_hsa04144 | 0.52384461 |
| 140 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51666806 |
| 141 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51455421 |
| 142 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47341300 |
| 143 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46382426 |
| 144 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46350440 |
| 145 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46233550 |
| 146 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46111948 |
| 147 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45973431 |
| 148 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44213949 |
| 149 | Insulin secretion_Homo sapiens_hsa04911 | 0.43155288 |
| 150 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43136987 |
| 151 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42930562 |
| 152 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42460288 |
| 153 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39924336 |
| 154 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.38684683 |
| 155 | Nicotine addiction_Homo sapiens_hsa05033 | 0.38514859 |
| 156 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36752063 |
| 157 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35230333 |
| 158 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34813211 |
| 159 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34660422 |
| 160 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33832748 |
| 161 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.33560923 |
| 162 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33278338 |
| 163 | Circadian entrainment_Homo sapiens_hsa04713 | 0.31646453 |
| 164 | GABAergic synapse_Homo sapiens_hsa04727 | 0.31438393 |
| 165 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30954167 |
| 166 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30401134 |
| 167 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30329721 |
| 168 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30075159 |
| 169 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.29421614 |
| 170 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.29188350 |
| 171 | Homologous recombination_Homo sapiens_hsa03440 | 0.29110510 |
| 172 | RNA degradation_Homo sapiens_hsa03018 | 0.28841004 |
| 173 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.27445428 |
| 174 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.26716269 |
| 175 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26478952 |
| 176 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.25948144 |
| 177 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.25303069 |
| 178 | Tight junction_Homo sapiens_hsa04530 | 0.24648443 |
| 179 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.24308751 |
| 180 | Platelet activation_Homo sapiens_hsa04611 | 0.23916855 |
| 181 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.20476554 |
| 182 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.19576378 |
| 183 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.19222714 |
| 184 | Insulin resistance_Homo sapiens_hsa04931 | 0.17110535 |
| 185 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.14920772 |
| 186 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.10749163 |
| 187 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.10708900 |
| 188 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09420015 |

